What You Should Know:
- GoodRx today announced it is working with Sanofi, a global leader in diabetes care, to offer a new way for people living with diabetes to access Lantus® (insulin glargine injection) 100 Units/mL in the U.S. for only $35.
- This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap out-of-pocket costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. It leverages GoodRx’s reach
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Ozempic: From Diabetes Management to Potential Weight Loss Miracle
You've probably heard about Ozempic, especially if you're one of the millions who regularly scroll through TikTok or browse other social media platforms. It's the drug that influencers are lauding as a revolutionary aid for weight loss, making it a hot topic of conversation.
While Ozempic was initially developed to manage Type 2 diabetes, its emerging potential for weight loss is captivating medical professionals and the public alike.
How Ozempic Works: The Basics
Ozempic is a
Read More
Diabetes Management in 2023 and Beyond: A Tech-Enabled Partnership Between Patient and Doctor
While the pandemic has slowed, there appears to be no end in sight to the diabetes epidemic. The number of individuals diagnosed is projected to keep growing over the next decade. What’s more concerning is that 75% of patients don’t meet guideline-based goals for A1C, blood pressure, and cholesterol control. Uncontrolled diabetes can lead to serious complications like heart disease, kidney failure, blindness, and even amputations.
Thankfully, more patients are embracing technology-based
Read More
CareFirst BlueCross BlueShield, Ryse Health Partner to Accelerate VBC for Diabetes Patients
What You Should Know:
Today, CareFirst BlueCross BlueShield (CareFirst), the largest not- for-profit health plan in the mid-Atlantic region, and Ryse Health (Ryse), an operator of specialized cardiometabolic health clinics, announced a first of its kind quality improvement partnership serving individuals with uncontrolled type 2 diabetes in CareFirst’s commercial networks.The program will pair Ryse providers with CareFirst members in Washington, D.C., Maryland, and Northern
Read More
Abbott, American Diabetes Association Launches Therapeutic Nutrition Program for People with Diabetes
What You Should Know:
American Diabetes Association® (ADA) and Abbott announced a collaboration a new collaboration on a pilot therapeutic nutrition program to help people living with Type 2 diabetes.The collaboration aims to understand how diabetes technology like continuous glucose monitoring (CGM) systems can help people living with diabetes make informed decisions about their food and activity.
Abbott’s $2.6M Grant to Support Diabetes
Abbott is providing a $2.65 million grant
Read More
Rimidi Enhances Integration with Dexcom, Adds Glycemic Risk Index to Diabetes Platform
What You Should Know:
Rimidi, a clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, is announcing enhancements to its diabetes management platform, including the addition of Glycemic Risk Index (GRI) as an emerging tool for patient and population outcomes management.
The inclusion of CGM data and GRI into Rimidi’s platform and clinical workflows is made possible via an enhanced integration with Dexcom, a
Read More
Ascensia Diabetes Care Partners with SNAQ to Support Mealtime Decision-Making
What You Should Know:
- Ascensia Diabetes Care, a global diabetes care company announces a landmark global collaboration with SNAQ, an award-winning app-based solution that offers key insights on food and nutrition for people with diabetes (PWDs).
- As part of the strategic collaboration, Ascensia and SNAQ will integrate their solutions to empower more PWDs to make impactful mealtime decisions, with a goal to improve diabetes management.
Support Mealtime Decision-Making
Read More
Blood Sugar Monitoring Devices Pose Wearability & Use Problems for Older Diabetic Adults & Caregivers
What You Should Know:
- In an initial trial of continuous glucometer use, faulty device adhesive -- a serious wearability challenge -- and patient difficulty in interpreting graphs produced by the device, were noted. In a subsequent trial, 70 older adults with diabetes wore glucometers and activity monitors and used smartphones and electronic medication bottles to track and manage blood sugar over a two-week period.
- Among these 70 patients, two-thirds of whom were African American and
Read More
Blue Shield of California, Virta Health Partners to Reverse Type 2 Diabetes in California
What You Should Know:
- Blue Shield of California has expanded its partnership with Virta Health to help reverse the human and financial impact of type 2 diabetes in the state.
- The partnership marks Blue Shield as the first health plan in California to implement a digital diabetes reversal solution across multiple lines of business.
Blue Shield is first health plan in California to implement digital diabetes reversal solution across multiple lines of business.
As part of Blue
Read More
Omada Health, Intermountain, Castell to Establish Integrated, Virtual Care Option for Diabetes Management and Prevention
What You Should Know:
- Omada Health and Castell, an Intermountain value-based care subsidiary, announced a first-of-its kind partnership – creating a new, integrated virtual care model to reach and help more at-risk patients through proven prevention and Diabetes programs.
The new virtual care model expands the access of Omada’s Diabetes Prevention Program and Diabetes Program to patients and caregivers receiving care from Intermountain Healthcare’s primary care providers
Read More
